RESEARCH · GHK-Cu · GENE EXPRESSION
GHK-Cu and Gene Expression: Connectivity Map Signatures, Collagen, MMPs and ECM Remodeling
GHK (glycyl-L-histidyl-L-lysine) is a tripeptide with high affinity for copper(II), and its copper complex, GHK-Cu, is one of the most studied matrix-related peptides. Our earlier articles cover the overall copper-peptide research picture and skin permeation and formulation. This article looks at a different layer: what gene-expression and extracellular-matrix (ECM) studies actually measured, from fibroblast cultures in the late 1980s to Connectivity Map analyses. PurixLab’s GHK-Cu 50mg is a research material for laboratory research use only.
Early fibroblast matrix studies
The first matrix-synthesis report came from Maquart and colleagues, who found that GHK-Cu stimulated collagen synthesis by cultured fibroblasts. The effect began between 10(-12) and 10(-11) M, was maximal at 10(-9) M and was independent of any change in cell number. They also noted that a GHK triplet occurs in the α2(I) chain of type I collagen, suggesting the tripeptide could be liberated by proteases at a wound site [1]. In normal human fibroblasts, GHK-Cu produced a biphasic increase in glycosaminoglycan synthesis, maximal at 10(-9) to 10(-8) M and returning toward control rates at higher concentrations; it preferentially stimulated extracellular dermatan sulfate and cell-layer heparan sulfate and did not affect hyaluronic acid [2]. Biphasic concentration-response is a recurring theme in this literature and a practical point for anyone designing cell experiments.
Wound chambers: collagen mRNA, proteoglycans and MMPs
In rat experimental wound chambers, GHK-Cu produced a concentration-dependent increase in dry weight, DNA, total protein, collagen and glycosaminoglycans. Type I and type III collagen mRNAs increased but TGF-β mRNAs did not, and a control tripeptide, L-glutamyl-L-histidyl-L-proline, had no significant effect [3]. Follow-up work in the same model found that GHK-Cu raised decorin mRNA and lowered biglycan mRNA in wound tissue, while in dermal fibroblast culture decorin expression rose and biglycan was unchanged [4].
The degradation side was studied too. Wound fluid contained interstitial collagenase, MMP-9 and MMP-2; GHK-Cu did not alter collagenase activity but increased pro-MMP-2 and activated MMP-2 during the later stages of healing (days 18 and/or 22) [5]. In cultured dermal fibroblasts, GHK-Cu increased MMP-2 levels and MMP-2 mRNA, an effect reproduced by copper ions but not by GHK alone, and it also increased secretion of the inhibitors TIMP-1 and TIMP-2 [6]. Together these studies frame GHK-Cu as modulating both matrix synthesis and remodeling, rather than simply building collagen.
Growth factors and collagen subtypes
Pollard and colleagues grew normal and irradiated human dermal fibroblasts in serum-free medium. With GHK-Cu at 1 x 10(-9) mol/L, population-doubling times were faster than in untreated controls, and irradiated fibroblasts produced significantly more basic fibroblast growth factor and VEGF early after exposure [7]. A 2023 study used qRT-PCR in human dermal fibroblasts to show that GHK-Cu combined with hyaluronic acid increased collagen I, IV and VII expression, with collagen IV raised 25.4 times in cells and 2.03 times in an ex vivo skin model at the best ratio tested [8].
From microarrays to the Connectivity Map
Much of the gene-expression literature on GHK rests on the Connectivity Map (CMap): a reference collection of expression profiles from cultured human cells treated with bioactive small molecules, with pattern-matching software that finds compounds whose profiles mimic or oppose a disease signature [9]. Hong and colleagues analysed genome-wide expression in 82 colorectal-cancer patients and controls, derived a 54-gene metastasis-prone signature, and found in a CMap query that Gly-His-Lys and securinine could significantly reverse the signature’s differential expression [10].
The most detailed study comes from Campbell and colleagues. They profiled 64 lung-tissue samples, 8 regions from each of 8 lungs from smokers with COPD, and identified 127 genes whose expression tracked regional emphysema severity. Genes that decreased with destruction were enriched in repair processes, including the TGF-β pathway, actin organisation and integrin signalling [11]. CMap identified GHK as able to reverse this signature, and the group then tested it directly: GHK-treated human fibroblasts recapitulated TGF-β-induced expression patterns, organised the actin cytoskeleton and expressed more integrin β1, and GHK or TGF-β restored collagen I contraction and remodeling by fibroblasts from COPD lungs [11]. In a mouse bleomycin model, GHK reduced collagen deposition, improved the MMP-9/TIMP-1 imbalance and reversed increases in TGF-β1 and phosphorylated Smad2 and Smad3 [12].
Where the “thousands of genes” figure comes from
Reviews by Pickart and co-authors extended CMap analyses and state that GHK is capable of up- and downregulating at least 4,000 human genes [13], discussing genes linked to the ubiquitin-proteasome system, DNA repair, antioxidant systems and TGF-β superfamily signalling [14]. These figures come from reanalysis of CMap expression data rather than from new, dedicated transcriptome experiments, and the reviews are written by researchers long associated with GHK [14,13]. Because CMap profiles were generated in cultured human cells exposed to compounds [9], a connectivity score indicates the direction of expression change in those cells, not an effect in intact tissue.
What remains open
- Few independent transcriptomes. Only a handful of primary datasets test GHK directly; most gene counts are CMap-derived [11,13].
- Copper versus peptide. Some effects, such as fibroblast MMP-2 induction, were reproduced by copper ions alone [6].
- Concentration windows. Responses can be biphasic, with stimulation lost at higher concentrations [2,1].
- Model dependence. Rat wound chambers, mouse lungs and cultured fibroblasts answer different questions [3,12].
GHK-Cu 50mg at PurixLab
GHK-Cu 50mg: a labelled lyophilized research vial with 50mg per vial, C$49 per vial (CAD, before tax), supplied for laboratory research only. It is not a cosmetic; our separate Copper Facial Mask is the finished cosmetic product. Batch documentation is available on request. Product page: purixlab.com/product/ghk-cu-50mg/.
PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.
In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge, and then you pay. There is no storefront or local pickup.
Payment is by Interac e-Transfer (instructions are shown at checkout) or by cryptocurrency through Plisio (Bitcoin, Ethereum, USDT and more): choose Plisio at checkout and you are sent to a secure Plisio payment page after placing the order. Current offers and any pack pricing are shown on the product page and in your cart; offers do not stack.
For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.
Questions or batch documentation requests: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ
References
- Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-6. PubMed 3169264 · doi:10.1016/0014-5793(88)80509-x
- Wegrowski Y, Maquart FX, Borel JP. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sci. 1992;51(13):1049-56. PubMed 1522753 · doi:10.1016/0024-3205(92)90504-i
- Maquart FX, Bellon G, Chaqour B, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest. 1993;92(5):2368-76. PubMed 8227353 · PMC288419 · doi:10.1172/JCI116842
- Siméon A, Wegrowski Y, Bontemps Y, et al. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 2000;115(6):962-8. PubMed 11121126 · doi:10.1046/j.1523-1747.2000.00166.x
- Siméon A, Monier F, Emonard H, et al. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. J Invest Dermatol. 1999;112(6):957-64. PubMed 10383745 · doi:10.1046/j.1523-1747.1999.00606.x
- Siméon A, Emonard H, Hornebeck W, et al. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257-65. PubMed 11045606 · doi:10.1016/s0024-3205(00)00803-1
- Pollard JD, Quan S, Kang T, et al. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Arch Facial Plast Surg. 2005;7(1):27-31. PubMed 15655171 · doi:10.1001/archfaci.7.1.27
- Jiang F, Wu Y, Liu Z, et al. Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests. J Cosmet Dermatol. 2023;22(9):2598-2604. PubMed 37062921 · doi:10.1111/jocd.15763
- Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929-35. PubMed 17008526 · doi:10.1126/science.1132939
- Hong Y, Downey T, Eu KW, et al. A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis. 2010;27(2):83-90. PubMed 20143136 · doi:10.1007/s10585-010-9305-4
- Campbell JD, McDonough JE, Zeskind JE, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012;4(8):67. PubMed 22937864 · PMC4064320 · doi:10.1186/gm367
- Zhou XM, Wang GL, Wang XB, et al. GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition. Front Pharmacol. 2017;8:904. PubMed 29311918 · PMC5733019 · doi:10.3389/fphar.2017.00904
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PubMed 26236730 · PMC4508379 · doi:10.1155/2015/648108
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: resetting the human genome to health. Biomed Res Int. 2014;2014:151479. PubMed 25302294 · PMC4180391 · doi:10.1155/2014/151479